Steven L. Krill, EVP & Chief Scientific Officer at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 10,000 shares at $76.69 ($767K) on 2016-12-20, disclosed to the SEC on 2017-01-04.
Open-market sale of $767k EGRX by EVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| EGRX | SELL | 2017-03-24 | $569K | — | Filing → |
| EGRX | SELL | 2017-01-04 | $756K | — | Filing → |
| EGRX | SELL | 2017-01-04 | $7.0M | — | Filing → |